2024-09-092025-09-302025-09-30false15943585HERBAMELIA LTD2026-05-26falseiso4217:GBPxbrli:pure159435852024-09-08159435852025-09-30159435852024-09-092025-09-30159435852024-09-07159435852024-09-08159435852024-09-082024-09-0815943585bus:SmallEntities2024-09-092025-09-3015943585bus:AuditExempt-NoAccountantsReport2024-09-092025-09-3015943585bus:FullAccounts2024-09-092025-09-3015943585bus:PrivateLimitedCompanyLtd2024-09-092025-09-3015943585core:WithinOneYear2025-09-3015943585core:AfterOneYear2025-09-3015943585core:WithinOneYear2024-09-0815943585core:AfterOneYear2024-09-0815943585core:ShareCapital2025-09-3015943585core:SharePremium2025-09-3015943585core:RevaluationReserve2025-09-3015943585core:OtherReservesSubtotal2025-09-3015943585core:RetainedEarningsAccumulatedLosses2025-09-3015943585core:ShareCapital2024-09-0815943585core:SharePremium2024-09-0815943585core:RevaluationReserve2024-09-0815943585core:OtherReservesSubtotal2024-09-0815943585core:RetainedEarningsAccumulatedLosses2024-09-0815943585core:LandBuildings2025-09-3015943585core:PlantMachinery2025-09-3015943585core:Vehicles2025-09-3015943585core:FurnitureFittings2025-09-3015943585core:OfficeEquipment2025-09-3015943585core:NetGoodwill2025-09-3015943585core:IntangibleAssetsOtherThanGoodwill2025-09-3015943585core:ListedExchangeTraded2025-09-3015943585core:UnlistedNon-exchangeTraded2025-09-3015943585core:LandBuildings2024-09-0815943585core:PlantMachinery2024-09-0815943585core:Vehicles2024-09-0815943585core:FurnitureFittings2024-09-0815943585core:OfficeEquipment2024-09-0815943585core:NetGoodwill2024-09-0815943585core:IntangibleAssetsOtherThanGoodwill2024-09-0815943585core:ListedExchangeTraded2024-09-0815943585core:UnlistedNon-exchangeTraded2024-09-0815943585core:LandBuildings2024-09-092025-09-3015943585core:PlantMachinery2024-09-092025-09-3015943585core:Vehicles2024-09-092025-09-3015943585core:FurnitureFittings2024-09-092025-09-3015943585core:OfficeEquipment2024-09-092025-09-3015943585core:NetGoodwill2024-09-092025-09-3015943585core:IntangibleAssetsOtherThanGoodwill2024-09-092025-09-3015943585core:ListedExchangeTraded2024-09-092025-09-3015943585core:UnlistedNon-exchangeTraded2024-09-092025-09-3015943585core:MoreThanFiveYears2024-09-092025-09-3015943585core:Non-currentFinancialInstruments2025-09-3015943585core:Non-currentFinancialInstruments2024-09-0815943585dpl:CostSales2024-09-092025-09-3015943585dpl:DistributionCosts2024-09-092025-09-3015943585core:LandBuildings2024-09-092025-09-3015943585core:PlantMachinery2024-09-092025-09-3015943585core:Vehicles2024-09-092025-09-3015943585core:FurnitureFittings2024-09-092025-09-3015943585core:OfficeEquipment2024-09-092025-09-3015943585dpl:AdministrativeExpenses2024-09-092025-09-3015943585core:NetGoodwill2024-09-092025-09-3015943585core:IntangibleAssetsOtherThanGoodwill2024-09-092025-09-3015943585dpl:GroupUndertakings2024-09-092025-09-3015943585dpl:ParticipatingInterests2024-09-092025-09-3015943585dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-092025-09-3015943585core:ListedExchangeTraded2024-09-092025-09-3015943585dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-092025-09-3015943585core:UnlistedNon-exchangeTraded2024-09-092025-09-3015943585dpl:CostSales2024-09-082024-09-0815943585dpl:DistributionCosts2024-09-082024-09-0815943585core:LandBuildings2024-09-082024-09-0815943585core:PlantMachinery2024-09-082024-09-0815943585core:Vehicles2024-09-082024-09-0815943585core:FurnitureFittings2024-09-082024-09-0815943585core:OfficeEquipment2024-09-082024-09-0815943585dpl:AdministrativeExpenses2024-09-082024-09-0815943585core:NetGoodwill2024-09-082024-09-0815943585core:IntangibleAssetsOtherThanGoodwill2024-09-082024-09-0815943585dpl:GroupUndertakings2024-09-082024-09-0815943585dpl:ParticipatingInterests2024-09-082024-09-0815943585dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-082024-09-0815943585core:ListedExchangeTraded2024-09-082024-09-0815943585dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-082024-09-0815943585core:UnlistedNon-exchangeTraded2024-09-082024-09-0815943585core:NetGoodwill2025-09-3015943585core:IntangibleAssetsOtherThanGoodwill2025-09-3015943585core:LandBuildings2025-09-3015943585core:PlantMachinery2025-09-3015943585core:Vehicles2025-09-3015943585core:FurnitureFittings2025-09-3015943585core:OfficeEquipment2025-09-3015943585core:AfterOneYear2025-09-3015943585core:WithinOneYear2025-09-3015943585core:ListedExchangeTraded2025-09-3015943585core:UnlistedNon-exchangeTraded2025-09-3015943585core:ShareCapital2025-09-3015943585core:SharePremium2025-09-3015943585core:RevaluationReserve2025-09-3015943585core:OtherReservesSubtotal2025-09-3015943585core:RetainedEarningsAccumulatedLosses2025-09-3015943585core:NetGoodwill2024-09-0815943585core:IntangibleAssetsOtherThanGoodwill2024-09-0815943585core:LandBuildings2024-09-0815943585core:PlantMachinery2024-09-0815943585core:Vehicles2024-09-0815943585core:FurnitureFittings2024-09-0815943585core:OfficeEquipment2024-09-0815943585core:AfterOneYear2024-09-0815943585core:WithinOneYear2024-09-0815943585core:ListedExchangeTraded2024-09-0815943585core:UnlistedNon-exchangeTraded2024-09-0815943585core:ShareCapital2024-09-0815943585core:SharePremium2024-09-0815943585core:RevaluationReserve2024-09-0815943585core:OtherReservesSubtotal2024-09-0815943585core:RetainedEarningsAccumulatedLosses2024-09-0815943585core:NetGoodwill2024-09-0715943585core:IntangibleAssetsOtherThanGoodwill2024-09-0715943585core:LandBuildings2024-09-0715943585core:PlantMachinery2024-09-0715943585core:Vehicles2024-09-0715943585core:FurnitureFittings2024-09-0715943585core:OfficeEquipment2024-09-0715943585core:AfterOneYear2024-09-0715943585core:WithinOneYear2024-09-0715943585core:ListedExchangeTraded2024-09-0715943585core:UnlistedNon-exchangeTraded2024-09-0715943585core:ShareCapital2024-09-0715943585core:SharePremium2024-09-0715943585core:RevaluationReserve2024-09-0715943585core:OtherReservesSubtotal2024-09-0715943585core:RetainedEarningsAccumulatedLosses2024-09-0715943585core:AfterOneYear2024-09-092025-09-3015943585core:WithinOneYear2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:CostValuation2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-092025-09-3015943585core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3015943585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3015943585core:Non-currentFinancialInstrumentscore:CostValuation2024-09-0815943585core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-0815943585core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-0815943585bus:Director12024-09-092025-09-30

HERBAMELIA LTD

Registered Number
15943585
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2025

HERBAMELIA LTD
Company Information
for the period from 9 September 2024 to 30 September 2025

Director

JUSKIENE, Kristina

Registered Address

14 Edge Street
Bilston
WV14 8HS

Registered Number

15943585 (England and Wales)
HERBAMELIA LTD
Balance Sheet as at
30 September 2025

Notes

2025

£

£

Fixed assets
Intangible assets32,700
2,700
Current assets
Stocks41,500
Debtors5818
Cash at bank and on hand4,342
6,660
Creditors amounts falling due within one year6(17,198)
Net current assets (liabilities)(10,538)
Total assets less current liabilities(7,838)
Net assets(7,838)
Capital and reserves
Called up share capital1
Profit and loss account(7,839)
Shareholders' funds(7,838)
The financial statements were approved and authorised for issue by the Director on 26 May 2026, and are signed on its behalf by:
JUSKIENE, Kristina
Director
Registered Company No. 15943585
HERBAMELIA LTD
Notes to the Financial Statements
for the period ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

2025
Average number of employees during the year1
3.Intangible assets

Goodwill

Total

££
Cost or valuation
Additions3,0003,000
At 30 September 253,0003,000
Amortisation and impairment
Charge for year300300
At 30 September 25300300
Net book value
At 30 September 252,7002,700
At 08 September 24--
4.Stocks

2025

£
Raw materials and consumables1,500
Total1,500
5.Debtors: amounts due within one year

2025

£
Trade debtors / trade receivables560
Prepayments and accrued income258
Total818
6.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables483
Amounts owed to related parties16,715
Total17,198
7.Related party transactions
During the year interest free loans were made available to the business by directors of £16,715.